NIH-funded research R21 grant

Understanding how aging affects memory and familiarity in older adults

Official title: Dopaminergic Mechanism for Familiarity and Memory Interference

Funded at Advanced Science Research Center · NIH-10989092 · Data updated 2026-11-12

This study looks at how changes in the brain as we age can affect memory and our ability to tell old memories from new ones, focusing on older adults and how certain brain areas might make it harder to learn new things when we have lots of memories already.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionAdvanced Science Research Center
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$434,500
NIH project number1R21AG085288-01A1
Project IDNIH-10989092 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults aged 65 and above who may be experiencing cognitive decline or memory impairment.

Less likely to help

Patients under the age of 65 or those without any cognitive impairment may not benefit from this research.

What this research studies

This research investigates how age-related changes in the brain, specifically in dopamine neurons, affect memory and the ability to distinguish between familiar and new information in older adults. The study focuses on the role of the lateral entorhinal cortex (LEC) and how its dysfunction may lead to increased memory interference, where established memories disrupt the learning of new information. By examining these neural circuits in older mice, the research aims to uncover the mechanisms behind cognitive decline and memory issues associated with aging.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for improving memory function and cognitive health in older adults.

How similar studies have gone: Previous research has indicated that understanding the role of dopamine in memory processing has shown promise, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Advanced Science Research Center
    New York, United States
    Active

Researchers

  • Principal investigator: Passos Mingote, Susana — Advanced Science Research Center
  • Study coordinator: Passos Mingote, Susana

Related research

Other NIH-funded projects on the same topics.

  • Pathway-Specific Vulnerability of Dopamine-Glutamate Neurons in Aging and Memory

    Aging may weaken specific dopamine- glutamate brain cells, which could help explain memory and motivation changes as we get older.

    NIH research Advanced Science Research Center · New York, United States · NIH-11434782

  • PAS proteins: How signaling switches work in cells

    A scientist team is studying PAS domains to understand how cells sense and respond to changes, with potential uses in medicine and biotechnology.

    NIH research Advanced Science Research Center · New York, United States · NIH-11359593

  • How myelin-making brain cells sense their surroundings

    Learning how the brain's myelin-producing cells respond to signals could help people with conditions like multiple sclerosis and age-related decline.

    NIH research Advanced Science Research Center · New York, United States · NIH-11322081

  • How tau protein clumps form and behave in different brain cells

    This project looks at how the tau protein forms sticky condensates in brain cells and how that may lead to early changes in Alzheimer's and related dementias.

    NIH research Advanced Science Research Center · New York, United States · NIH-11310173

  • Harmful changes in brain immune cells in Alzheimer's

    This work looks at how brain immune cells called microglia become damaging in Alzheimer's disease and whether reversing a stress pathway can stop that harm.

    NIH research Advanced Science Research Center · New York, United States · NIH-11245789

  • Understanding tau protein behavior in Alzheimer's disease

    This study is looking at how changes in a protein called tau might lead to Alzheimer's disease and other types of dementia, focusing on how it behaves in brain cells, especially those that help keep our brains healthy, to find new ways to treat or prevent these conditions.

    NIH research Advanced Science Research Center · New York, United States · NIH-11080308

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.